ANN LEDET: Open Payments
NPI 1104068824 · LULING, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 13 payments from 8 companies in 2025. Trend: 2023 $768 · 2024 $1,568 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $63 |
| Janssen Biotech, Inc. | 3 | $60 |
| Daiichi Sankyo Inc. | 2 | $51 |
| GENZYME CORPORATION | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $18 |
Products named: SARCLISA, TALVEY, EPKINLY, VENCLEXTA, DATROWAY, KISQALI, KEYTRUDA, Nubeqa.
Industry payments across LA — which companies pay providers there.
